TY  - GEN
AU  - Pilorge,Sylvain
AU  - Rigaudeau,Sophie
AU  - Rabian,Florence
AU  - Sarkozy,Clémentine
AU  - Taksin,Anne L
AU  - Farhat,Hassan
AU  - Merabet,Fathia
AU  - Ghez,Stéphanie
AU  - Raggueneau,Victoria
AU  - Terré,Christine
AU  - Garcia,Isabelle
AU  - Renneville,Aline
AU  - Preudhomme,Claude
AU  - Castaigne,Sylvie
AU  - Rousselot,Philippe
TI  - Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse
SN  - 1096-8652
PY  - 2014///0515
KW  - Aged
KW  - Aminoglycosides
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Compassionate Use Trials
KW  - Consolidation Chemotherapy
KW  - Cytarabine
KW  - Daunorubicin
KW  - Disease-Free Survival
KW  - Female
KW  - Filgrastim
KW  - Gemtuzumab
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Immunophenotyping
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Leukemia, Myelomonocytic, Acute
KW  - Male
KW  - Methylprednisolone
KW  - Middle Aged
KW  - Neutropenia
KW  - chemically induced
KW  - Nucleophosmin
KW  - Recombinant Proteins
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Thrombocytopenia
KW  - blood
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/ajh.23653
ER  -